
Carveko 3.125 Tablet
Marketer
SAG Health Science Pvt Ltd
Salt Composition
Carvedilol (3.125mg)
Overview Carveko 3.125 Tablet
Cardiovasc 3.125mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving cardiac blood flow. Reduced blood pressure contributes to stroke and myocardial infarction prevention. Administer Cardiovasc 3.125mg tablets with food, following your physician's prescribed dosage and schedule. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinue only under medical supervision to avoid potential complications. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed), enhance therapeutic benefits. While generally well-tolerated, potential side effects include vertigo, cephalalgia, dyspnea, and fatigue. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions to your physician. Consult your doctor before using this medication during pregnancy or lactation.
Uses of Carveko 3.125 Tablet
Managing elevated blood pressure | Alleviating angina pectoris | Treating congestive heart failure
Major Benefits of Carveko 3.125 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Carveko 3.125 Tablet with food.
Common Side effects of Carveko 3.125 Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carveko 3.125 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carveko 3.125mg tablets should be administered with a meal.
How Carveko 3.125 Tablet works:
Carveko 3.125 mg tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Carveko 3.125 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Carveko 3.125 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Use of Carveko 3.125 mg tablets while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Carveko 3.125 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Carveko 3.125 mg tablets are suitable for patients with impaired kidney function; no dosage alteration is typically needed. Nevertheless, disclose any pre-existing kidney conditions to your physician. Routine blood pressure checks are advised to guide any necessary dose modifications.
LiverCAUTION
Patients with liver impairment should use Carveko 3.125 mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. Carveko 3.125 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Carveko 3.125 Tablet :
Should you forget a Carveko 3.125 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Carveko 3.125 Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-propanol derivative |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Alpha-beta blocker |
